Klacid Od

Clarithromycin, the active ingredient in Klacid Od, is a macrolide antibiotic presented as an oral dosage form for oral use. It treats a range of bacterial infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Klacid Od as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is used to treat infections caused by susceptible bacteria across several organ systems.

- Community‑acquired pneumonia: eradicates the causative bacterial pathogens and resolves pulmonary infection. - Acute bacterial sinusitis: reduces sinus inflammation by eliminating the infecting organisms. - Skin and soft‑tissue infections: clears susceptible Staphylococcus and Streptococcus species from affected tissues. - Helicobacter pylori eradication (in combination therapy): contributes to bacterial eradication as part of a multi‑drug regimen for ulcer disease.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: frequent loose stools, sometimes watery. - Abdominal pain: cramping or discomfort in the stomach area. - Taste disturbance: altered or metallic taste perception. - Headache: mild to moderate head pain. - Vomiting: occasional expulsion of stomach contents.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis): rapid onset of hives, swelling, or breathing difficulty. - QT interval prolongation: potential for cardiac arrhythmias. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Clostridioides difficile‑associated diarrhea: severe colitis after antibiotic use. - Stevens‑Johnson syndrome: serious skin and mucous membrane disorder. - Cardiac arrhythmias: irregular heart rhythms beyond QT prolongation.

Before initiating clarithromycin therapy, consider the following safety measures.

- Assess renal function: adjust therapy if significant impairment exists. - Monitor liver enzymes: watch for signs of hepatotoxicity during treatment. - Avoid in known macrolide allergy: risk of hypersensitivity reactions. - Use caution with QT‑prolonging drugs: increased risk of cardiac arrhythmia. - Pregnancy and breastfeeding: discuss potential risks with the prescriber. - Store at room temperature: keep in the original container, protect from moisture.

Clarithromycin can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise clarithromycin plasma levels. - Statins such as simvastatin or lovastatin: increased risk of rhabdomyolysis. - Other QT‑prolonging agents (e.g., quinidine, amiodarone): heightened arrhythmia risk.

Moderate Interactions (Monitor Closely): - Warfarin: may potentiate anticoagulant effect, requiring INR monitoring. - Carbamazepine: may reduce clarithromycin concentrations, diminishing efficacy. - Theophylline: may increase theophylline levels, leading to toxicity.